𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?

✍ Scribed by Tam, Constantine S.; Keating, Michael J.

Book ID
115497437
Publisher
Informa plc
Year
2012
Tongue
English
Weight
200 KB
Volume
54
Category
Article
ISSN
1042-8194

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What is the current evidence for antigen
What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia?
✍ Gerard Tobin; Anders Rosén; Richard Rosenquist 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

For many years it has been evident that B-cell chronic lymphocytic leukemia (CLL) displays preferential usage of individual immunoglobulin (Ig) variable heavy chain (V(H)) genes. The V(H)1-69 gene was the first to be reported overrepresented in a large number of CLL patients, where the V(H)1-69(+) C